Stryker Growth Driven by Mako and ASC Gains

Stryker's logo

Stryker reported 3Q20 orthopedic revenue of USD $1,944.5 million, +4.2% vs. 3Q19. The progressive return of elective procedures and demand for Mako drove the company’s V-shaped recovery from the second quarter pandemic low point. While recovery momentum attenuated throughout the quarter, 3Q20 marked a return to growth for struggling Stryker...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us